Published in Pharmacoepidemiol Drug Saf on September 29, 2014
Validity and completeness of colorectal cancer diagnoses in a primary care database in the United Kingdom. Pharmacoepidemiol Drug Saf (2015) 0.85
Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies. PLoS One (2017) 0.75
Factors Associated with Upper Gastrointestinal Cancer Occurrence After Endoscopy that Did Not Diagnose Cancer. Dig Dis Sci (2016) 0.75
Digoxin reduces the mutagenic effects of Mitomycin C in human and rodent cell lines. Cytotechnology (2017) 0.75
The Read clinical classification. BMJ (1990) 15.83
The General Practice Research Database: quality of morbidity data. Popul Trends (1997) 7.07
Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf (2007) 5.93
Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth. Proc Natl Acad Sci U S A (2008) 4.79
Feasibility study and methodology to create a quality-evaluated database of primary care data. Inform Prim Care (2004) 4.39
Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology (2001) 3.51
Biased selection of controls for case-control analyses of cohort studies. Biometrics (1984) 3.25
The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf (2005) 3.24
A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment. Cancer Discov (2011) 2.77
Use of statins and risk of fractures. JAMA (2001) 2.47
HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs. Oncogene (2011) 2.42
Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA (2007) 1.79
Cancer incidence in The Health Improvement Network. Pharmacoepidemiol Drug Saf (2009) 1.65
Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med (2012) 1.63
The problem of "protopathic bias" in case-control studies. Am J Med (1980) 1.41
Cardiac glycosides inhibit p53 synthesis by a mechanism relieved by Src or MAPK inhibition. Cancer Res (2009) 1.27
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci U S A (2012) 1.27
Trial watch: Cardiac glycosides and cancer therapy. Oncoimmunology (2013) 1.21
Up-regulation of Na(+),K(+)-ATPase alpha 3-isoform and down-regulation of the alpha1-isoform in human colorectal cancer. FEBS Lett (2004) 1.09
Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. J Nat Prod (2009) 1.07
Digoxin use and the risk of breast cancer in women. J Clin Oncol (2011) 1.07
Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study. Breast Cancer Res (2008) 1.07
Cardiac glycosides induce autophagy in human non-small cell lung cancer cells through regulation of dual signaling pathways. Int J Biochem Cell Biol (2012) 1.06
Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol (2012) 1.00
Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells. J Biol Chem (2011) 0.97
Molecular pathways: digoxin use and estrogen-sensitive cancers--risks and possible therapeutic implications. Clin Cancer Res (2012) 0.92
The effects of nonspecific HIF1α inhibitors on development of castrate resistance and metastases in prostate cancer. Cancer Med (2014) 0.91
Increased risk of colorectal cancer in type 2 diabetes is independent of diet quality. PLoS One (2013) 0.85
A cohort study of digoxin exposure and mortality in men with prostate cancer. BJU Int (2013) 0.84
Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix. Int J Cancer (2011) 0.82
Digoxin use and risk of invasive breast cancer: evidence from the Nurses' Health Study and meta-analysis. Breast Cancer Res Treat (2014) 0.82
Src mediates extracellular signal-regulated kinase 1/2 activation and autophagic cell death induced by cardiac glycosides in human non-small cell lung cancer cell lines. Mol Carcinog (2014) 0.82
Is digoxin use for cardiovascular disease associated with risk of prostate cancer? Prostate (2013) 0.81
Ouabain, a cardiac glycoside, inhibits the Fanconi anemia/BRCA pathway activated by DNA interstrand cross-linking agents. PLoS One (2013) 0.80
Digoxin downregulates NDRG1 and VEGF through the inhibition of HIF-1α under hypoxic conditions in human lung adenocarcinoma A549 cells. Int J Mol Sci (2013) 0.79
Breast cancer in women using digoxin: tumor characteristics and relapse risk. Breast Cancer Res (2013) 0.78
Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ (2013) 3.22
Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol (2003) 2.20
Rates of malignancy associated with juvenile idiopathic arthritis and its treatment. Arthritis Rheum (2012) 2.15
Antibiotic exposure and IBD development among children: a population-based cohort study. Pediatrics (2012) 2.04
Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med (2008) 1.99
Physician attitudes toward regionalization of adult critical care: a national survey. Crit Care Med (2009) 1.79
Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst (2012) 1.69
Validity of The Health Improvement Network (THIN) for epidemiologic studies of hepatitis C virus infection. Pharmacoepidemiol Drug Saf (2009) 1.61
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk. J Natl Cancer Inst (2014) 1.50
Association between proton pump inhibitor use and spontaneous bacterial peritonitis. Dig Dis Sci (2007) 1.50
Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol (2014) 1.45
Antibiotic exposure and the risk for depression, anxiety, or psychosis: a nested case-control study. J Clin Psychiatry (2015) 1.43
Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for Zollinger-Ellison syndrome. Pancreas (2013) 1.41
Study design for a comprehensive assessment of biologic safety using multiple healthcare data systems. Pharmacoepidemiol Drug Saf (2011) 1.30
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database. Pharmacoepidemiol Drug Saf (2013) 1.23
Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Hepatology (2012) 1.16
Prevalence and treatment patterns of psoriatic arthritis in the UK. Rheumatology (Oxford) (2012) 1.15
Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding risk. Am J Med (2010) 1.11
Validation of The Health Improvement Network (THIN) database for epidemiologic studies of chronic kidney disease. Pharmacoepidemiol Drug Saf (2011) 1.11
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study. Ann Rheum Dis (2012) 1.08
Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms. Obstet Gynecol (2008) 1.07
No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol (2011) 1.05
Diagnostic E-codes for commonly used, narrow therapeutic index medications poorly predict adverse drug events. J Clin Epidemiol (2008) 1.05
Validity of psoriatic arthritis and capture of disease modifying antirheumatic drugs in the health improvement network. Pharmacoepidemiol Drug Saf (2014) 1.04
Do diabetes drugs modify the risk of pancreatic cancer? Gastroenterology (2009) 1.04
Metformin and survival in pancreatic cancer: a retrospective cohort study. Pancreas (2013) 1.03
Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf (2012) 0.99
Cholecystectomy and the risk of colorectal cancer. Am J Gastroenterol (2005) 0.98
Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer (2012) 0.96
Distinguishing incident and prevalent diabetes in an electronic medical records database. Pharmacoepidemiol Drug Saf (2013) 0.93
Hip fracture risk in patients with a diagnosis of pernicious anemia. Gastroenterology (2009) 0.93
Patient reported receipt of medication instructions for warfarin is associated with reduced risk of serious bleeding events. J Gen Intern Med (2008) 0.89
Insulin therapy and colorectal adenomas in patients with diabetes mellitus. Cancer Epidemiol Biomarkers Prev (2012) 0.88
Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf (2008) 0.88
Ayurveda and yoga in cardiovascular diseases. Cardiol Rev (2005) 0.88
Use of antiepileptic drugs in patients with kidney disease. Semin Dial (2006) 0.87
Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study. Pharmacoepidemiol Drug Saf (2014) 0.87
Pharmacogenomics training using an instructional software system. Am J Pharm Educ (2011) 0.87
Emergent renal dysfunction with colistin pharmacotherapy. Pharmacotherapy (2013) 0.86
Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies. Pharmacoepidemiol Drug Saf (2012) 0.86
Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures. J Clin Epidemiol (2007) 0.85
Stimulant treatment and injury among children with attention deficit hyperactivity disorder: an application of the self-controlled case series study design. Inj Prev (2012) 0.85
Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer. Pharmacoepidemiol Drug Saf (2014) 0.85
Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients. Arthritis Care Res (Hoboken) (2015) 0.85
Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol (2007) 0.84
Risks and benefits of menopausal hormone therapy in postmenopausal Chinese women. Menopause (2012) 0.84
Uses of proton pump inhibitors and serum potassium levels. Pharmacoepidemiol Drug Saf (2009) 0.84
Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf (2015) 0.81
Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer (2014) 0.81
Observational cohort study of the safety of digoxin use in women with heart failure. BMJ Open (2012) 0.80
Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure. Hepatology (2005) 0.79
Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol (2005) 0.79
Barrett's esophagus in 2008: an update. Keio J Med (2008) 0.79
Risk of community-acquired pneumonia in patients with a diagnosis of pernicious anemia: a population-based retrospective cohort study. Eur J Gastroenterol Hepatol (2015) 0.79
Electronic clinical laboratory test results data tables: lessons from Mini-Sentinel. Pharmacoepidemiol Drug Saf (2014) 0.78
Changes of the HSD17B10 gene expression levels in ulcerative colitis. Inflamm Bowel Dis (2013) 0.78
Findings on serial surveillance colonoscopy in patients with low-risk polyps on initial colonoscopy. J Clin Gastroenterol (2010) 0.77
Proton pump inhibitors do not impair the effectiveness of metformin in patients with diabetes. Br J Clin Pharmacol (2015) 0.77
Granulomatosis and testicular germ cell tumors. Urology (2012) 0.77
Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis. Ann Surg (2016) 0.76
Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76
Diagnosis of pernicious anemia and the risk of pancreatic cancer. Pancreas (2014) 0.75
Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors. Clin Nucl Med (2015) 0.75
A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis. Inflamm Bowel Dis (2017) 0.75
Risk of colorectal cancer in women with a prior diagnosis of gynecologic malignancy. J Clin Gastroenterol (2007) 0.75
Fetal alcohol spectrum disorder and the neurobehavioural screening tool: evaluating the effect of maternal depression. J Popul Ther Clin Pharmacol (2014) 0.75
Factors Predicting Testing and Treatment of Iron Deficiency in a Nationwide Cohort of Anemic UC Patients. Inflamm Bowel Dis (2016) 0.75
Rates of COVID-19-related Outcomes in Cancer compared to non-Cancer Patients. medRxiv (2020) 0.75
Efficacy of Peptide Receptor Radionuclide Therapy in a United States-Based Cohort of Metastatic Neuroendocrine Tumor Patients: Single-Institution Retrospective Analysis. Pancreas (2017) 0.75